Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages

Glioblastoma (GBM) is the most aggressive type of brain tumor. In this context, animal models represent excellent tools for the early detection and longitudinal mapping of neuronal dysfunction, that are critical in the preclinical validation of new therapeutic strategies. In a mouse glioma model, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannini, Eleonora, Maltese, Federica, Olimpico, Francesco, Fabbri, Alessia, Costa, Mario, Caleo, Matteo, Baroncelli, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410325/
https://www.ncbi.nlm.nih.gov/pubmed/28212563
http://dx.doi.org/10.18632/oncotarget.15328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410325/
https://www.ncbi.nlm.nih.gov/pubmed/28212563
http://dx.doi.org/10.18632/oncotarget.15328

Ejemplares similares